1. Baseline prevalence and predictors of liver fibrosis among HIV‐positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. (April 2015) Authors: Matthews, GV; Neuhaus, J; Bhagani, S; Mehta, SH; Vlahakis, E; Doroana, M; Naggie, S; Arenas‐Pinto, A; Peters, L; Rockstroh, JK Journal: HIV medicine Issue: Volume 16(2015)Supplement 1 Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗